In line with their study, we showed that inhibiting DDX5 suppressed the growth of HER2+ tumors in vivo, suggesting that DDX5 is likely one of the important regulators for mammary tumors induced by 17q23 amplification. The gene discussed is ERBB2; the disease is breast cancer.